Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2014
 •  Black Friday — What To Expect?  •  Boys to Men  •  FDA OKs Valeant's New Acne Treatment  •  FBC Holdings Signs Deal with Valentine Beauty  •  Smoky Black Friday for MAC
Print

SkinMedica: Mary M. Fisher



Published June 23, 2008
Related Searches: growth gel products skin
Post a comment
SkinMedica:
has appointed Mary M. Fisher as chief executive officer. Ms. Fisher was previously chief operating officer at Acorda Therapeutics, a biotechnology company focused on developing products for the treatment of central nervous system disorders. During her seven years at Acorda, she also served as executive vice president of commercial operations and vice president of marketing and strategic planning. As chief operating officer, she played a key role in Acorda’s success, including its successful IPO and the subsequent strong operating performance and impressive growth in shareholder value. Prior to Acorda, Ms. Fisher was vice president of commercial operations with Cephalon. Her earlier career includes positions with Immunex and Boehringer Ingelheim.


blog comments powered by Disqus